Study to Assess Efficacy and Safety of Cx601, Adult Allogeneic Expanded Adipose-derived Stem Cells (eASC) for the Treatment of Complex Perianal Fistula(s) in Participants With Crohn's Disease (CD) (ADMIRE-CD-II)
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT03279081 |
|
Recruitment Status :
Completed
First Posted : September 12, 2017
Last Update Posted : January 12, 2024
|
Sponsor:
Tigenix S.A.U.
Information provided by (Responsible Party):
Takeda ( Tigenix S.A.U. )
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Completed |
|---|---|
| Actual Primary Completion Date : | January 23, 2023 |
| Actual Study Completion Date : | July 26, 2023 |
| Certification/Extension First Submitted : | January 11, 2024 |